Actively Recruiting
Evaluating Cefazolin Levels in Cerebrospinal Fluid During Ventricular Shunt Surgery to Assess Antibiotic Protection
Led by University Hospital, Strasbourg, France · Updated on 2026-08-20
15
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the concentration of the antibiotic cefazolin in the cerebrospinal fluid CSF during ventricular shunt surgery to see if the standard prophylactic dose of 2 grams is adequate to protect the valve from infections. The study also aims to compare these results with existing pharmacokinetic models of cefazolin diffusion and explore clinical factors that might explain any differences found. Participants will receive a cefazolin antibiotic prophylaxis dose prior to surgery. During the operation, when the dura mater is opened just before valve implantation, the concentration of cefazolin in the cerebrospinal fluid will be measured. Blood samples will also be taken before the injection and at multiple intervals afterward 30 minutes, 1 hour, and 2 hours to assess blood cefazolin levels. Participants will be involved during their scheduled ventricular shunt surgery at the hospital. Researchers will collect cerebrospinal fluid and blood samples at specific times to measure cefazolin concentrations. The main outcome is the cefazolin level in the cerebrospinal fluid, with secondary outcomes measuring blood levels over time. The study focuses on monitoring these concentrations to better understand antibiotic protection during surgery, with no long-term follow-up mentioned.
CONDITIONS
Brief Title
Cefazolin Antibiotic Prophylaxis in Ventricular Shunt Surgery: Determination of Cerebrospinal Fluid Concentration During Valve Implantation
Research Team
B
Baptiste BOUCHIER, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here